 |
Previous Article | Next Article 
The Journal of Neuroscience, May 15, 1999, 19(10):4011-4022
The Stimulatory Action and the Development of Tolerance to
Caffeine Is Associated with Alterations in Gene Expression in Specific
Brain Regions
Per
Svenningsson,
George G.
Nomikos, and
Bertil B.
Fredholm
Section of Molecular Neuropharmacology, Department of Physiology
and Pharmacology, Karolinska Institutet, 17177 Stockholm, Sweden
We sought neurochemical correlates to the stimulatory action of
caffeine in rats and to adaptations during development of tolerance.
Acute intraperitoneal injections of caffeine (7.5 mg/kg) increased
locomotion and NGFI-A mRNA, a marker of neuronal activity, in
the hippocampal area CA1, but decreased NGFI-A mRNA in rostral striatum
and nucleus accumbens. Rats that received caffeine (0.3 gm/l) in their
drinking water for 14 d developed tolerance to the stimulatory
effect of a challenge with caffeine (7.5 mg/kg) and responded with a
less pronounced decrease of NGFI-A mRNA in rostral striatum and nucleus
accumbens. Metabolism of caffeine to its active metabolites was
increased in tolerant animals, but the total level of active
metabolites in brain was not significantly altered. Thus, there are
changes in caffeine metabolism after long-term caffeine treatment, but
they cannot explain development of tolerance.
Caffeine-tolerant animals had downregulated levels of adenosine
A2A receptors and the corresponding mRNA in rostral parts of striatum, but an increased expression of adenosine A1
receptor mRNA in the lateral amygdala. No changes in mesencephalic
tyrosine hydroxylase mRNA were found in caffeine-tolerant rats.
Thus, we have identified neuronal pathways that are regulated by
adenosine A1 and/or A2A receptors and are
targets for the stimulatory action of caffeine. Furthermore, adaptive
changes in gene expression in these brain areas were associated with
the development of locomotor tolerance to caffeine.
Key words:
caffeine; methylxanthines; adenosine receptors; immediate
early genes; striatum; drug tolerance; locomotion; in situ
hybridization
Copyright © 1999 Society for Neuroscience 0270-6474/99/19104011-12$05.00/0
This article has been cited by other articles:

|
 |

|
 |
 
F. Ciruela, V. Casado, R. J. Rodrigues, R. Lujan, J. Burgueno, M. Canals, J. Borycz, N. Rebola, S. R. Goldberg, J. Mallol, et al.
Presynaptic Control of Striatal Glutamatergic Neurotransmission by Adenosine A1-A2A Receptor Heteromers
J. Neurosci.,
February 15, 2006;
26(7):
2080 - 2087.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. E. Fedele, N. Gouder, M. Guttinger, L. Gabernet, L. Scheurer, T. Rulicke, F. Crestani, and D. Boison
Astrogliosis in epilepsy leads to overexpression of adenosine kinase, resulting in seizure aggravation
Brain,
October 1, 2005;
128(10):
2383 - 2395.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. B. Fredholm and P. Svenningsson
Adenosine-dopamine interactions: Development of a concept and some comments on therapeutic possibilities
Neurology,
December 9, 2003;
61(90116):
S5 - 9.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
D. S. Kim and R. D. Palmiter
Adenosine receptor blockade reverses hypophagia and enhances locomotor activity of dopamine-deficient mice
PNAS,
February 4, 2003;
100(3):
1346 - 1351.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Bastia and M. A. Schwarzschild
DARPP Chocolate: A Caffeinated Morsel of Striatal Signaling
Sci. Signal.,
January 14, 2003;
2003(165):
pe2 - pe2.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. B. Fredholm, A. P. IJzerman, K. A. Jacobson, K.-N. Klotz, and J. Linden
International Union of Pharmacology. XXV. Nomenclature and Classification of Adenosine Receptors
Pharmacol. Rev.,
December 1, 2001;
53(4):
527 - 552.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Johansson, L. Halldner, T. V. Dunwiddie, S. A. Masino, W. Poelchen, L. Gimenez-Llort, R. M. Escorihuela, A. Fernandez-Teruel, Z. Wiesenfeld-Hallin, X.-J. Xu, et al.
Hyperalgesia, anxiety, and decreased hypoxic neuroprotection in mice lacking the adenosine A1 receptor
PNAS,
July 19, 2001;
(2001)
161292398.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Johansson, L. Halldner, T. V. Dunwiddie, S. A. Masino, W. Poelchen, L. Gimenez-Llort, R. M. Escorihuela, A. Fernandez-Teruel, Z. Wiesenfeld-Hallin, X.-J. Xu, et al.
Hyperalgesia, anxiety, and decreased hypoxic neuroprotection in mice lacking the adenosine A1 receptor
PNAS,
July 31, 2001;
98(16):
9407 - 9412.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|